Literature DB >> 30191002

Our panel of experts highlight the most important research articles across the spectrum of topics relevant to the field of hepatic oncology.

Jennifer Owens1,2,1,2, Heather Francis1,2,1,2.   

Abstract

Year:  2015        PMID： 30191002      PMCID： PMC6095171          DOI： 10.2217/hep.15.15

Source DB:  PubMed          Journal:  Hepat Oncol        ISSN： 2045-0923


× No keyword cloud information.
  17 in total

1.  Periostin activates integrin α5β1 through a PI3K/AKT‑dependent pathway in invasion of cholangiocarcinoma.

Authors:  Kusumawadee Utispan; Jumaporn Sonongbua; Peti Thuwajit; Siri Chau-In; Chawalit Pairojkul; Sopit Wongkham; Chanitra Thuwajit
Journal:  Int J Oncol       Date:  2012-06-25       Impact factor: 5.650

Review 2.  Epithelial cell adhesion molecule expression (CD326) in cancer: a short review.

Authors:  Carlo Patriarca; Roberto Maria Macchi; Anja K Marschner; Hakan Mellstedt
Journal:  Cancer Treat Rev       Date:  2011-05-14       Impact factor: 12.111

Review 3.  Periostin in intrahepatic cholangiocarcinoma: pathobiological insights and clinical implications.

Authors:  Alphonse E Sirica; Jorge A Almenara; Chao Li
Journal:  Exp Mol Pathol       Date:  2014-10-28       Impact factor: 3.362

4.  Toxicology and carcinogenesis studies of 2,3',4,4',5-pentachlorobiphenyl (PCB 118) (CAS No. 31508-00-6) in female harlan Sprague-Dawley rats (gavage studies).

Authors: 
Journal:  Natl Toxicol Program Tech Rep Ser       Date:  2010-11

5.  The alphavbeta6 integrin is a highly specific immunohistochemical marker for cholangiocarcinoma.

Authors:  E Patsenker; L Wilkens; V Banz; C H Osterreicher; R Weimann; S Eisele; A Keogh; D Stroka; A Zimmermann; F Stickel
Journal:  J Hepatol       Date:  2010-01-13       Impact factor: 25.083

6.  Integrins αvβ6, α6β4 and α3β1 are down-regulated in cholangiolocellular carcinoma but not cholangiocarcinoma.

Authors:  Yurie Soejima; Masafumi Inoue; Yoshihisa Takahashi; Hiroshi Uozaki; Motoji Sawabe; Toshio Fukusato
Journal:  Hepatol Res       Date:  2014-04-24       Impact factor: 4.288

7.  Epithelial cell adhesion molecule-positive human hepatic neoplastic cells: development of combined hepatocellular-cholangiocarcinoma in mice.

Authors:  Sachiko Ogasawara; Jun Akiba; Masamichi Nakayama; Osamu Nakashima; Takuji Torimura; Hirohisa Yano
Journal:  J Gastroenterol Hepatol       Date:  2015-02       Impact factor: 4.029

Review 8.  Cholangiocarcinoma.

Authors:  Boris R A Blechacz; Gregory J Gores
Journal:  Clin Liver Dis       Date:  2008-02       Impact factor: 6.126

9.  Lineage-dependent effects of aryl hydrocarbon receptor agonists contribute to liver tumorigenesis.

Authors:  Joshua A Harrill; Bethany B Parks; Eliane Wauthier; J Craig Rowlands; Lola M Reid; Russell S Thomas
Journal:  Hepatology       Date:  2015-01-05       Impact factor: 17.425

10.  The novel colorectal cancer biomarkers CDO1, ZSCAN18 and ZNF331 are frequently methylated across gastrointestinal cancers.

Authors:  Hege Marie Vedeld; Kim Andresen; Ina Andrassy Eilertsen; Arild Nesbakken; Raquel Seruca; Ivar P Gladhaug; Espen Thiis-Evensen; Torleiv O Rognum; Kirsten Muri Boberg; Guro E Lind
Journal:  Int J Cancer       Date:  2014-06-28       Impact factor: 7.396
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.